Table 1. Clinical characteristics of the subjects.
n (male/female) | 17 (14/3) |
Age (years) | 31.7 ± 1.3 |
Body mass index (kg/m2) | 23.1 ± 0.9 |
Fasting plasma glucose (mmol/L) | 6.1 ± 0.2 |
Fasting insulin (pmol/L) | 25.2 ± 3.7 |
HbA1c (%) | 4.7 ± 0.0 |
Triglycerides (mmol/L) | 2.00 ± 0.31 |
Total cholesterol (mmol/L) | 4.56 ± 0.16 |
HDL‐cholesterol (mmol/L) | 1.51 ± 0.10 |
Insulinogenic index | 66.22 ± 8.54 |
HOMA β‐cell | 60.85 ± 8.89 |
HOMA‐IR | 0.94 ± 0.15 |
ISI composite | 11.45 ± 1.67 |
Means ± SE. HDL, high‐density lipoprotein; HOMA, homeostasis model assessment; HOMA‐IR, homeostasis model assessment of insulin resistance; ISI, insulin sensitivity index.